Maruti Suzuki India plans Rs. 775 billion investment through FY31
Autocar Professional, 1 September '26
Maruti Suzuki India plans to invest Rs. 775 billion (US$ 8.17 billion) over the five years from FY2026-27 to FY2030-31 to expand production capacity, develop new models and strengthen its research and development (R&D) capabilities.
Responding to a shareholder query at the company's 45th annual general meeting, Managing Director and CEO Hisashi Takeuchi said that the expenditure would cover capacity expansion, new-model development, R&D, plant maintenance, marketing and sales infrastructure, carbon-reduction measures and logistics.
Maruti Suzuki's FY27 capex to increase 40% to Rs. 140 billion
For FY2026-27, Maruti Suzuki has planned capital expenditure of Rs. 140 billion, representing a 40% increase from the Rs. 100 billion invested in FY2025-26. The investment programme will cover manufacturing capacity expansion, product portfolio development, domestic sales, exports and related operations.
Capacity expansion and multi-powertrain strategy
Capacity expansion is expected to account for part of the programme, alongside spending on new products and technology. Maruti Suzuki is pursuing a multi-powertrain strategy covering CNG, hybrid, electric vehicle and internal-combustion engine technologies in response to customer demand and emission requirements.
Investment in marketing, sales infrastructure and logistics will support the company's domestic network and export operations, while spending on carbon reduction will cover measures to lower emissions across its products and manufacturing operations.
Rs. 775 billion plan: Annual spending breakdown
The Rs. 775 billion programme represents an average annual investment of Rs. 155 billion over five years. With Rs. 140 billion planned for FY27, the remaining Rs. 635 billion would imply average annual spending of nearly Rs. 159 billion over the subsequent four years. Annual investment could therefore increase as capacity, product and technology programmes progress towards FY31.